However, further research is needed to confirm the clinical utility of serum sRAGE as a biomarker in canine CIE and determine if sRAGE/RAGE pathways present a potential novel therapeutic target in dogs with chronic gastrointestinal inflammation (198, 199). The gene discussed is AGER; the disease is congenital non-bullous ichthyosiform erythroderma.